bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (BIAF)

CUSIP: 09076W109

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 6 signals
Share change
-96,201
SEC-reported price per share
$0.29
Number of holders
17
Value change
-$25,253
Number of buys
10
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
28,694,438

Security key

09076W109

Report period

Q2 2025

Institutions

17

Top holders

10

Ownership snapshot

Top reported holders of BIAF - bioAffinity Technologies, Inc. - Common Stock, par value $0.007 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Richard K. Crumly
Disclosed value leader
Gary D. Rubin
Comparable rows
1/15
Latest evidence
07 May 2025
13D/G 3/4/5 Lead comparable stake: 11% 14 rows are not safely comparable across share classes. 13D/G row: Richard K. Crumly Showing 1-6 of 15 holder rows.

Quick read

Richard K. Crumly leads the comparable SEC ownership view at 11%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Richard K. Crumly's linked filing trail.
Comparable ownership Top 1
Richard K. Crumly 11%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Richard K. Crumly
13D/G
11%
Reported 13D/G · 07 May 2025
$1,446,200
3,213,777 shares
$0 07 May 2025
Gary D. Rubin
3/4/5
Director, 10%+ Owner
—
denominator unverified
$4,586,464
1,730,741 shares
— 01 Jul 2024
Nathan M. Perlmutter
3/4/5
10%+ Owner
—
mixed-class rows
$2,213,386
399,653 shares
mixed-class rows
— 06 Sep 2022
Steven Girgenti
3/4/5
Executive Chairman, Director
—
denominator unverified
$2,846,638
1,089,017 shares
— 10 Jan 2025
Roby Joyce
3/4/5
Director
—
denominator unverified
$1,721,825
649,745 shares
— 01 Jul 2024
Maria Zannes
3/4/5
President & CEO, Director
—
denominator unverified
$644,803
280,359 shares
— 10 Jan 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
17
Shares
362,316
Rows available
17
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q2 2025 holders
17
Holder diff
16
Investor Q3 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q3 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .